176 related articles for article (PubMed ID: 32400191)
1. Subtypes of masked hypertension and target organ damage in untreated outpatients.
Zhang DY; Cheng YB; Guo QH; Wang Y; Sheng CS; Huang QF; An DW; Li MX; Huang JF; Xu TY; Wang JG; Li Y
Blood Press; 2020 Oct; 29(5):299-307. PubMed ID: 32400191
[No Abstract] [Full Text] [Related]
2. Ambulatory blood pressure is better associated with target organ damage than clinic blood pressure in patients with primary glomerular disease.
Wen RW; Chen XQ; Zhu Y; Ke JT; Du Y; Wang C; Lou TQ
BMC Nephrol; 2020 Dec; 21(1):541. PubMed ID: 33308181
[TBL] [Abstract][Full Text] [Related]
3. Masked hypertension in obesity: potential predictors and arterial damage.
Kenny IE; Saeed S; Gerdts E; Midtbø H; Halland H; Lønnebakken MT
Blood Press Monit; 2017 Feb; 22(1):12-17. PubMed ID: 27776078
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, determinants, and clinical significance of masked hypertension and white-coat hypertension in patients with chronic kidney disease.
Tang H; Gong WY; Zhang QZ; Zhang J; Ye ZC; Peng H; Wang C; Lou T
Nephrology (Carlton); 2016 Oct; 21(10):841-50. PubMed ID: 26566951
[TBL] [Abstract][Full Text] [Related]
5. Risk of Target Organ Damage in Children With Primary Ambulatory Hypertension: A Systematic Review and Meta-Analysis.
Chung J; Robinson CH; Yu A; Bamhraz AA; Ewusie JE; Sanger S; Mitsnefes M; Parekh RS; Raina R; Thabane L; Dionne JM; Chanchlani R
Hypertension; 2023 Jun; 80(6):1183-1196. PubMed ID: 36802759
[TBL] [Abstract][Full Text] [Related]
6. White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study.
Fukuhara M; Arima H; Ninomiya T; Hata J; Hirakawa Y; Doi Y; Yonemoto K; Mukai N; Nagata M; Ikeda F; Matsumura K; Kitazono T; Kiyohara Y
Stroke; 2013 Jun; 44(6):1512-7. PubMed ID: 23640825
[TBL] [Abstract][Full Text] [Related]
7. Similar levels of low-grade inflammation and arterial stiffness in masked and white-coat hypertension: comparisons with sustained hypertension and normotension.
Andrikou I; Tsioufis C; Dimitriadis K; Syrseloudis D; Valenti P; Almiroudi M; Lioni L; Tousoulis D; Stefanadis C
Blood Press Monit; 2011 Oct; 16(5):218-23. PubMed ID: 21914984
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, Determinants, and Clinical Significance of Masked Hypertension in a Population-Based Sample of African Americans: The Jackson Heart Study.
Diaz KM; Veerabhadrappa P; Brown MD; Whited MC; Dubbert PM; Hickson DA
Am J Hypertens; 2015 Jul; 28(7):900-8. PubMed ID: 25499058
[TBL] [Abstract][Full Text] [Related]
9. Blood Pressure Pattern and Target Organ Damage in Patients With Chronic Kidney Disease.
Scheppach JB; Raff U; Toncar S; Ritter C; Klink T; Störk S; Wanner C; Schlieper G; Saritas T; Reinartz SD; Floege J; Janka R; Uder M; Schmieder RE; Eckardt KU; Schneider MP
Hypertension; 2018 Oct; 72(4):929-936. PubMed ID: 30354716
[TBL] [Abstract][Full Text] [Related]
10. Alterations in diastolic function in masked hypertension: findings from the masked hypertension study.
Oe Y; Shimbo D; Ishikawa J; Okajima K; Hasegawa T; Diaz KM; Muntner P; Homma S; Schwartz JE
Am J Hypertens; 2013 Jun; 26(6):808-15. PubMed ID: 23446956
[TBL] [Abstract][Full Text] [Related]
11. Nocturnal pulse rate correlated with ambulatory blood pressure and target organ damage in patients with chronic kidney disease.
Zhang J; Wen R; Yin J; Zhu Y; Lin L; Ye Z; Peng H; Wang C; Lou T
J Clin Hypertens (Greenwich); 2019 Jan; 21(1):77-87. PubMed ID: 30597750
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of prehypertension and masked hypertension rate among clinically normotensive patients.
Unsal S; Ozkara A; Albayrak T; Ozturk Y; Beysel S; Kucukler FK
Clin Exp Hypertens; 2016; 38(2):218-24. PubMed ID: 26818410
[TBL] [Abstract][Full Text] [Related]
13. Masked hypertensives: A disguised arterial stiffness population.
Antza C; Doundoulakis I; Stabouli S; Tziomalos K; Kotsis V
J Clin Hypertens (Greenwich); 2019 Oct; 21(10):1473-1480. PubMed ID: 31498516
[TBL] [Abstract][Full Text] [Related]
14. Ambulatory blood pressure monitoring parameters in obese children and adolescents with masked hypertension.
Yegül-Gülnar G; Kasap-Demir B; Alparslan C; Çatli G; Mutlubaş F; Yavaşcan Ö; Özkan B; Dündar BN; Aksu N
Blood Press Monit; 2019 Dec; 24(6):277-283. PubMed ID: 31567187
[TBL] [Abstract][Full Text] [Related]
15. Night-time home versus ambulatory blood pressure in determining target organ damage.
Andreadis EA; Agaliotis G; Kollias A; Kolyvas G; Achimastos A; Stergiou GS
J Hypertens; 2016 Mar; 34(3):438-44; discussion 444. PubMed ID: 26727487
[TBL] [Abstract][Full Text] [Related]
16. Diagnosing Masked Hypertension Using Ambulatory Blood Pressure Monitoring, Home Blood Pressure Monitoring, or Both?
Anstey DE; Muntner P; Bello NA; Pugliese DN; Yano Y; Kronish IM; Reynolds K; Schwartz JE; Shimbo D
Hypertension; 2018 Nov; 72(5):1200-1207. PubMed ID: 30354812
[TBL] [Abstract][Full Text] [Related]
17. Subclinical arterial and cardiac damage in white-coat and masked hypertension.
Wojciechowska W; Stolarz-Skrzypek K; Olszanecka A; Klima Ł; Gąsowski J; Grodzicki T; Kawecka-Jaszcz K; Czarnecka D
Blood Press; 2016 Aug; 25(4):249-56. PubMed ID: 26953075
[TBL] [Abstract][Full Text] [Related]
18. Target organ damage and masked hypertension in the general population: the Finn-Home study.
Hänninen MR; Niiranen TJ; Puukka PJ; Kesäniemi YA; Kähönen M; Jula AM
J Hypertens; 2013 Jun; 31(6):1136-43. PubMed ID: 23466942
[TBL] [Abstract][Full Text] [Related]
19. Comparison of pulse wave velocity and pulse pressure amplification in association with target organ damage in community-dwelling elderly: The Northern Shanghai Study.
Bai B; Teliewubai J; Lu Y; Yu S; Xiong J; Chi C; Zhou Y; Ji H; Fan X; Blacher J; Li J; Zhang Y; Xu Y
Hypertens Res; 2018 May; 41(5):372-381. PubMed ID: 29535455
[TBL] [Abstract][Full Text] [Related]
20. Isolated nocturnal and isolated daytime hypertension associate with altered cardiovascular morphology and function in children with chronic kidney disease: findings from the Cardiovascular Comorbidity in Children with Chronic Kidney Disease study.
Düzova A; Karabay Bayazit A; Canpolat N; Niemirska A; Kaplan Bulut I; Azukaitis K; Karagoz T; Oguz B; Erdem S; Anarat A; Ranchin B; Shroff R; Djukic M; Harambat J; Yilmaz A; Yildiz N; Ozcakar B; Büscher A; Lugani F; Wygoda S; Tschumi S; Zaloszyc A; Jankauskiene A; Laube G; Galiano M; Kirchner M; Querfeld U; Melk A; Schaefer F; Wühl E;
J Hypertens; 2019 Nov; 37(11):2247-2255. PubMed ID: 31205198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
